MARKET

ASMB

ASMB

Assembly Bioscie
NASDAQ
11.33
-0.01
-0.09%
Opening 11:02 02/26 EST
OPEN
11.32
PREV CLOSE
11.34
HIGH
11.36
LOW
11.16
VOLUME
7.98K
TURNOVER
0
52 WEEK HIGH
20.04
52 WEEK LOW
7.69
MARKET CAP
62.12M
P/E (TTM)
-0.6610
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ASMB last week (0219-0223)?
Weekly Report · 21h ago
Assembly Biosciences (ASMB) Price Target Increased by 1100.00% to 36.72
NASDAQ · 3d ago
Weekly Report: what happened at ASMB last week (0212-0216)?
Weekly Report · 02/19 09:08
Assembly Biosciences Executes Reverse Stock Split
TipRanks · 02/13 21:33
Weekly Report: what happened at ASMB last week (0205-0209)?
Weekly Report · 02/12 09:07
Assembly Biosciences Announces Effective Date Of February 9, 2024 For 1-For-12 Reverse Stock Split
Assembly Bio common stock expected to begin trading on a split-adjusted basis on February 12, 2024. The biotechnology company expects a 1-for-12 reverse stock split of its outstanding shares of common stock to be effective as of February 9, 2024 . The company anticipates that its common stock will start trading on The Nasdaq Global Select Market under the same symbol (ASMB)
Benzinga · 02/08 13:20
Weekly Report: what happened at ASMB last week (0129-0202)?
Weekly Report · 02/05 09:08
Assembly Biosciences Announces 1-for-12 Reverse Stock Split
TipRanks · 02/03 09:22
More
About ASMB
Assembly Biosciences, Inc. is a clinical-stage biotechnology company engaged in the development of small molecule antiviral therapeutics. Its hepatitis B virus (HBV) pipeline includes potent, HBV core inhibitors in clinical development, which are designed to disrupt the virus replication cycle at several key points with a focus on achieving finite treatment and functional cures. Its HBV and hepatitis delta virus (HDV) pipeline also includes two complementary approaches: a viral entry inhibitor and an oral, liver-focused, interferon-alpha receptor agonist, with potential application for both HBV and as chronic suppressive therapy for HDV, which is associated with increased disease burden for HBV/HDV patients. The herpesvirus pipeline addresses two serious consequences associated with herpesvirus infections, high-recurrence genital herpes and transplant-associated herpesviruses. Its HBV and HDV programs include ABI-4334 (4334), ABI-5366 (5366), HBV/HDV inhibitor program, and others.

Webull offers Assembly Biosciences Inc stock information, including NASDAQ: ASMB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASMB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ASMB stock methods without spending real money on the virtual paper trading platform.